Serotonergic mechanisms play a central role in migraine pathology. However, the region-specific effects of serotonin (5-HT) mediated via multiple types of receptors in the nociceptive system are poorly understood. Using extracellular and patch-clamp recordings, we studied the action of 5-HT on the excitability of peripheral and central terminals of trigeminal afferents. 5-HT evoked long-lasting TTX-sensitive firing in the peripheral terminals of meningeal afferents, the origin site of migraine pain. Cluster analysis revealed that in majority of nociceptive fibers 5-HT induced either transient or persistent spiking activity with prevailing delta and theta rhythms. The 5-HT3-receptor antagonist MDL-72222 or 5-HT1B/D-receptor antagonist GR127935 largely reduced, but their combination completely prevented the excitatory pro-nociceptive action of 5-HT. The 5-HT3 agonist mCPBG activated spikes in MDL-72222-dependent manner but the 5HT-1 receptor agonist sumatriptan did not affect the nociceptive firing. 5-HT also triggered peripheral CGRP release in meninges, which was blocked by MDL-72222.5-HT evoked fast membrane currents and Ca 2þ transients in a fraction of trigeminal neurons. Immunohistochemistry showed expression of 5-HT3A receptors in fibers innervating meninges. Endogenous release of 5-HT from degranulated mast cells increased nociceptive firing. Low pH but not histamine strongly activated firing. 5-HT reduced monosynaptic inputs from trigeminal Ad-and C-afferents to the upper cervical lamina I neurons and this effect was blocked by MDL-72222. Consistent with central inhibitory effect, 5-HT reduced CGRP release in the brainstem slices. In conclusion, 5-HT evokes powerful pro-nociceptive peripheral and anti-nociceptive central effects in trigeminal system transmitting migraine pain.
Introduction
Migraine is a common neurological disorder which pathophysiology is still poorly understood. For decades, serotonergic mechanisms were supposed to play a key role in migraine pathology (Lance et al., 1967; Dussor, 2014; Hamel, 2007) . During migraine attacks, the plasma level of serotonin (5-HT) raises dramatically, whereas between attacks it goes down (Ferrari et al., 1989) . Early studies reported the ability of 5-HT to inhibit migraine attack (Lance et al., 1967) . In general, a low 5-HT level combined with high receptor sensitivity has been proposed as a factor increasing the risk of migraine (Panconesi, 2008) . However, because of a wide range of receptors for 5-HT and its region-specific effects on the nociceptive system (Saxena and Ferrari, 1992; Viguier et al., 2013) , there are a number of contradictory reports on the role of 5-HT in migraine (Cervantes-Dur an et al., 2013; Hamel, 2007) .
The 5-HT-caused pain is mediated, at least in part, via activation of perivascular nociceptive fibers innervating extracranial arteries (Koo and Balaban, 2006) . 5-HT also has pro-nociceptive action when applied to the dura mater as a component of the inflammatory soup (Strassman et al., 1996; Luk acs et al., 2015; Oshinsky and Gomonchareonsiri, 2007) . However, the mechanism of the 5-HTinduced pro-nociceptive effect at trigeminal nerve terminals in the meninges remains poorly understood. For example, sumatriptan, one of the most specific anti-migraine agents, is an agonist of the 5-HT1B and 5-HT1D receptors but the site of its action within the nociceptive system still remains to be elucidated (Dussor, 2014) . The 5-HT1B receptor is located on vascular smooth muscles and the 5-HT1D receptor on the peripheral and central terminals of the dural afferents (Harriott et al., 2012) . Thus, it is reasonable to suggest that both peripheral and central sites represent potential targets for anti-migraine therapy by triptans (Goadsby and Hoskin, 1998; Donaldson et al., 2002) . Indeed, Amrutkar et al. (2012) found that sumatriptan inhibited CGRP release both in dura mater and in the brainstem.
The meninges comprising pia and dura mater play one of the major roles in the generation of migraine headaches (Goadsby and Edvinsson, 1993; Strassman et al., 1996; Olesen et al., 2009; Zakharov et al., 2015) . Stimulation of the trigeminal ganglia induced release of the migraine mediator CGRP into cranial circulation and this effect was blocked by sumatriptan (Goadsby and Edvinsson, 1993) . Many key studies were performed in animal migraine models in vivo when meninges were stimulated after sensitization induced by inflammatory compounds and recordings were made either from trigeminal ganglion or from brainstem (Strassman et al., 1996; Goadsby and Hoskin, 1998; Burstein et al., 2005) . Meninges have a large number of 5-HT-containing mast cells considered as one of the migraine triggers (Levy, 2009) . Degranulation of mast cells in vivo induces a long-lasting activation of meningeal nociceptors (Levy et al., 2007) . Platelets containing 5-HT in their dense-body granules have also been suggested to contribute to some forms of migraine (Taffi et al., 2005; Borgdorff and Tangelder, 2012; Danese et al., 2014) .
The 5-HT3 receptor, the only ionotropic receptor in the extended 5-HT receptor family, mediates excitatory responses in the central and peripheral sensory neurons (Cervantes-Dur an et al., 2013; Hicks et al., 2002) . There are contradictory data on the functional role of 5-HT3 receptors in the spinal cord, as both proand anti-nociceptive effects were reported (Green et al., 2000; Kim et al., 2015; Oatway et al., 2004) . About 20% of descending serotonergic terminals make axo-axonal contacts with primary afferents (Zhang et al., 2015) , implying their involvement in the presynaptic control of peripheral inputs. In agreement with the pro-nociceptive action of 5-HT, 5-HT3 receptor antagonists are commonly used for pain therapy (Greenshaw and Silverstone, 1997; Sagalajev et al., 2015) . However, their mechanisms of action have not been studied in a migraine pain models, which may have its specific physiological properties and neurochemical profile.
Recently, we developed a novel cluster approach to analyze nociceptive discharges in isolated trigeminal fibers innervating cranial meninges, the origin site of migraine pain (Zakharov et al., 2015) . This technique overcomes several limitations of the in vivo experiments: one can directly record activity in nociceptive terminals under conditions of adequate drug concentration control and without application of concomitant anesthesia.
In the present study, we show that the robust activation of the peripheral nerve terminals by 5-HT is opposed by its inhibitory action on the central terminals, and that both these effects are mediated via the same 5-HT3 receptor.
Materials and methods

Preparations
Experiments were performed in accordance with the European Community Council Directive of September 22, 2010 . Wistar rats from the Animal House of the University of Eastern Finland were housed in cages with controlled temperature, humidity and 12-h light-dark cycle. Food and water were served ad libitum. The protocols were approved by the Animal Care and Use Committee of the University of Eastern Finland. The isolated rat hemiskulls were prepared from adult (5 weeks) male rats as described previously (Zakharov et al., 2015) . Briefly, the rats were decapitated after CO 2 inhalation, the skin and muscles were removed from the skull, which was divided into halves by a cut along the sagittal suture. The brain hemispheres were removed without harming the trigeminal ganglia and the meningeal dura mater.
For the whole-cell recordings, laboratory Wistar rats of both sexes (P15-18) were killed by decapitation in accordance with the Portuguese guidelines (Direcção Geral de Alimentação e Veterin aria, Minist erio da Agricultura) after anesthesia with intraperitoneal injection of Na þ -pentobarbital (30 mg/kg) and a subsequent check for a lack of pedal withdrawal reflexes. The experiments were carried out according to the guidelines laid down by the institution's animal welfare committee (Comissão de Etica do Instituto de Biologia Molecular e Celular). The trigeminospinal complex (the brainstem and the upper cervical spinal cord) with the trigeminal nerve attached was quickly isolated in oxygenated artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 115, KCl 3, CaCl 2 2, MgCl 2 1, NaH 2 PO 4 1, NaHCO 3 25 and glucose 11; (bubbled with 95% O 2 /5% CO 2 ) at room temperature. The pia mater in the spinal segments C1-C2 was locally removed with forceps and scissors, to provide access for the recording pipettes. The isolated trigeminospinal complex was glued with cyanoacrylate adhesive to a plate made of gold (the dorsolateral surface was up) and transferred to the recording chamber. Lamina I neurons in the C1-C2 segment were visualized through the intact white matter using the oblique infrared light-emitting-diode illumination technique (Safronov et al., 2007; Szucs et al., 2009) .
Primary cell cultures of trigeminal ganglia of Wistar male rats (P10-12, Animal Center of the University of Eastern Finland, Kuopio, Finland) were prepared as described previously . In brief, trigeminal ganglia were isolated and ganglion cells dissociated using an enzyme cocktail containing trypsin (0.25 mg/mL) and collagenase type I (760 U/mL) under continuous shaking (850 rpm) at 37 C for 15 min. Cells were plated on coverslips coated with poly-L-lysine (0.2 mg/ml, P1399, Sigma-Aldrich Co. St. Louis, MO USA) and cultured in F12 medium supplemented with FBS 10% (10270-106; Gibco Invitrogen, Carlsbad, CA, USA) at 37 C in an atmosphere saturated with 5% CO 2 for 48 h prior to Ca 2þ imaging.
Electrophysiology
The hemiskull preparation obtained from Wistar rats was used for the suction electrode recording of activity in the nervus spinosus, which is a part of the mandibular branch of the trigeminal nerve (Schueler et al., 2013) . The recording was carried out with a DAM80i amplifier (band pass 0.1e1000 Hz, gain 10,000) using firepolished glass microelectrodes with a tip diameter of~150 mm filled with ACSF. Spontaneous and drug-induced action potentials generated in the distal parts of the transected nervus spinosus were recorded at a room temperature of 20e22 C. We waited for stabilization of the baseline conditions for at least 15 min. Recordings of meningeal spikes in control (20 min) were followed by those in the presence of 5-HT or its agonists. Each concentration of the 5-HT agonists was tested in a new hemiskull preparation. All spikes were visually inspected to prevent inclusion of non-specific signals. All traces were digitized at 8 msec intervals using a NIPCI6221 data acquisition board (National Instruments, Austin, TX, USA) with WinEDR software (Strathclyde University, UK) and stored on a PC for off-line analysis.
Whole-cell recordings from lamina I neurons in the isolated trigeminospinal complex were done using the method described elsewhere (Pinto et al., 2010; Szucs et al., 2009 ). The pipettes were pulled from thick-walled glass (BioMedical Instruments, Z€ ollnitz, Germany) and fire-polished (resistance, 4e5 MU). The pipette solution contained (in mM): KCl 3, K-gluconate 150, MgCl 2 1, BAPTA 1, and HEPES 10 (pH 7.3 adjusted with KOH, final [K þ ] was 160 mM). The amplifier was an EPC10-Double (HEKA, Lambrecht, Germany). The signal was low-pass filtered at 2.9 kHz and sampled at 10 kHz. Offset potentials were compensated before seal formation. Liquid junction potentials were calculated and corrected using the compensation circuitry of the amplifier.
Primary afferent inputs were evoked by stimulating the trigeminal nerve via suction electrode as described in Pinto et al. (2010) using an isolated pulse stimulator (2100, A-M Systems, Sequim, WA, USA). A 50 ms pulse (600e850 mA) was applied to activate Ad fibers and a 1 ms pulse (600e850 mA) to activate both Ad and C fibers. Monosynaptic excitatory postsynaptic currents (EPSCs) were identified on the basis of low failure rates and small latency variations as described previously (Pinto et al., 2010) . The afferent conduction velocity (CV) was calculated by dividing the conduction distance by the conduction time. The former included the length of the trigeminal nerve from the opening of the suction electrode to its entry zone and the estimated pathway within the brainstem and spinal cord. The pathway was measured from video images and calculated as the sum of the rostrocaudal and mediolateral distances between the cell body and the trigeminal nerve entry zone. The Ad-fiber EPSCs were identified as those evoked by 50 ms stimulations and showing the afferent CV between 1.51 m/s and 0.7 m/s; the C-fiber EPSCs were evoked by 1 ms stimulations and their afferent CV was lower than 0.7 m/s. All measurements were done at 22e24 C.
Whole-cell patch clamp recordings from isolated trigeminal neurons were performed as described previously (Hautaniemi et al., 2012; Zakharov et al., 2015) using the PC-10 amplifier (HEKA Elektronik). Microelectrodes (4e5 MU) were filled with intracellular solution containing (in mM): 130 CsCl, 10 HEPES, 5 EGTA, 0.5 CaCl2, 5 MgCl2, 5 KATP, 0.5 NaGTP. The extracellular solution contained (in mM): 152 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose and 10 HEPES (pH adjusted to 7.4 with NaOH). Holding potential of neurons was À70 mV. 5-HT and mCPBG were applied through a rapid superfusion system BioLogic, Grenoble, France) . The data were analyzed using the software FitMaster (HEKA Elektronik).
Off-line cluster analysis of spikes
Acquisition of signals from the meningeal afferents and cluster analysis were carried out as described previously (Zakharov et al., 2015) . All spikes considered in this study had amplitudes exceeding the level of five s (standard deviation) of the background noise. The amplitude of each spike is expressed in the s values (arbitrary units, a.u.) . Amplitudes and durations of the positive and negative waves of extracellular spikes were used for the cluster separations. The analysis was performed with the MATLAB software (MathWorks, USA) and the KlustaKwik application (Kadir et al., 2014) was used for the spike cluster identification.
CGRP level determination
Measurement of the CGRP levels was performed with enzyme immunoassays kits (EIA kits, SPIbio, Montigny Le Bretonneux, France) and the samples obtained from hemiskulls were collected as described previously (Ebersberger et al., 1999; Gupta et al., 2010) . Each hemiskull with an intact dura mater was perfused for 30 min with ACSF at a room temperature. Then the hemiskulls were placed into Vaseline-filled chambers and the cavities were washed 3 times with 350 mL of ACSF for 15 min for stabilization and refilled with fresh ACSF. After the third stabilization/washing step the hemiskulls were refilled with the test compound solution in ACSF. After a 15 min incubation period, the liquid samples (250 ml) were collected after 15 min exposure to the testing compounds dissolved in ACSF by gentle pipetting without touching the dura mater. Samples then were put into the test tubes with EIA buffer containing the peptidase inhibitors. The tubes were immediately placed in liquid nitrogen. This protocol was carried out in duplicates. The rest of the assay protocol was carried out according to the manufacturer's instructions. Briefly, after wells were rinsed with the wash buffer, 100 mL of sample or CGRP standard were added into the relevant wells followed by the addition of 100 mL of anti-CGRP AChE tracer. The 96-well plates were incubated for the reaction at 4 C for 16e20 h and 200 mL of Ellman's reagent was added after removal of the supernatant. Brainstem slices were prepared from P10-12 rats as described previously (Kageneck et al., 2014; Wild et al., 2015) . Thus, the medullary brainstem was dissected and serial transverse slices (400 mm) were cut on a vibrotome (Campden instruments, Switzerland) in ice-cold ACSF. Two brainstem slices from each rat were transferred into a separate well of the 96 wells plate, supplemented with 125 ml of ACSF and kept at 37 C for 30 min. Then 100 ml of ACSF were taken to determine the basic level of CGRP. Next, either 100 ml of ACSF (control) or 100 ml of 20 mM 5-HT containing ACSF were added to different wells. After 15 min 100 ml samples from each well were taken to determine CGRP levels. Samples were tested in duplicate by using CGRP-EIA kit. Optical density of the wells was measured at 405 nm using an ELISA reader (microplate photometer, Wallac VICTOR2™, PerkinElmer, Waltham, Massachusetts, USA). The calibration curve was obtained by using standards with defined CGRP concentrations.
Histochemistry
The isolated hemiskulls of male P34-36 Wistar rats were fixed in 4% paraformaldehyde for 2 h, then the dura mater was carefully dissected and post-fixed for 3 h in the same fixative. The tissue was intensively washed with PBS, pH 7.4 three times for 15 min, and then incubated for 1 h with PBS containing 10% normal goat serum (NGS, Jackson Immunores. Lab. Inc., West Grove, PA, USA), 2% BSA and 0.5% Tween 20, Sigma, Munich, Germany) for permeabilization and to block unspecific protein binding. A mixture of primary antibodies (rabbit anti-5HT3 3A, Cat. number ASR-031, Alomone Labs, Jerusalem, Israel, and mouse anti-neurofilament light chain, Invitrogen, Carlsbad, California, USA) diluted 1:300 in a buffer was added to the dura mater preparations. After overnight incubation at 4 C the samples were washed 3 times for 1 h with the same buffer, and finally with the permeabilizing solution (1% NGS, 2% BSA, 0.5% Tween 20 in PBS, pH 7.4) for 1 h. Secondary antibodies such as donkey anti-rabbit IgG, Alexa Fluor 488-conjugated (Invitrogen, Carlsbad, California, USA) at a dilution of 1:1000 and the goat antimouse IgG, biotin conjugated (Jackson Immunores. Lab. Inc., West Grove, PA, USA) at a dilution of 1:200, were added to the samples for 3 h. After the intensive wash, the dura mater samples were incubated with AMCA-conjugated streptavidin (Jackson Immunores. Lab. Inc., USA) for 1 h, washed, and cover slipped with an aqua mount medium (Sigma, Munich, Germany). The labelling was evaluated by epifluorescence microscopy (Olympus IX70, Tokyo, Japan) using appropriate filter combinations. Controls with secondary antibodies omitted, or pre-incubation of primary antibodies with molar excess of a corresponding peptide 5HT3A (342e355; ASR-031, Alomone Labs.) were processed simultaneously and gave negative results.
For visualization of mast cells, dura maters were detached from the skull and perfused with oxygenated ACSF for 10 min for stabilization. Then dura samples were exposed to the compound 48/ 80 (10 mg/ml) for ten minutes, and then fixed with 4% paraformaldehyde in PBS overnight. Whole-mount preparations were stained with toluidine blue (pH: 2.5) for observation of mast cells under the stage of the Olympus microscope AX 70.
Ca 2þ imaging
To study the response of cultured trigeminal ganglion cells to 5-HT and capsaicin, intracellular Ca 2þ transients were measured. Cells were loaded with the Ca 2þ sensitive fluorescent dye Fluo-3 AM (5 mM, F1242, Life technologies) in F12 medium supplemented with FBS 10% (10270-106; Gibco Invitrogen, Carlsbad, California, USA) for 45 min at 37 C. Then cells were washed out for 15 min with a BSS and transferred to a chamber continuously perfused with a basic solution. Images were acquired using a microscope imaging setup (TILL Photonics GmbH, Munich, Germany) with a monochromatic light source (excitation 488 nm) and the emitted fluorescence was monitored using the respective filters and a 12-bit CCD camera (SensiCam, Kelheim, Germany). 5-HT (20 mM, 20 s) and capsaicin (1 mM, 2 s) were applied via a fast perfusion system (Rapid Solution
Changer RSC-200, BioLogic Science Instruments, Grenoble, France), followed by the application of the 50 mM-KCl-containing solution to differentiate neurons from glia . Data were analyzed off-line using TILL Photonics and Origin (MicroCal, Northampton, MA, USA) software.
Statistical analysis
The paired two-sided Wilcoxon rank sum test or t-test for paired samples was performed to assess the discrepancy of parameters calculated under different conditions in the same preparation, and the unpaired Wilcoxon test or t-test was used for comparing different preparations. The level of significance was set at 0.05. Statistical treatments of the data were carried out using Statistics toolbox (MATLAB) or Origin software. Averaged values are presented as mean ± SEM.
Theory
Migraine pain originates from the peripheral branches of the trigeminal nerve supplying meninges. To be able to 'treat pain at the source', we have to better understand early steps in activation of peripheral meningeal afferents. Until now, functional studies of the peripheral pain traffic were mainly focused on in vivo recordings from higher nociceptive-processing centers and had several limitations, i.e. effects of surgery and anesthesia, poor control of applied drug concentration and contamination by activity of local neuronal networks at the site of recording. Although serotonin (5-HT) is widely accepted as a contributor to migraine pathology, reports on the mechanisms of its action are very contradictory due to expression of multiple types of 5-HT receptors in the nociceptive system. We have recently developed the cluster analysis of nociceptive spikes recorded from trigeminal nerve terminals in the isolated dura mater preparation. Here, we used this approach to study in details the complex effect of 5-HT on excitation in different parts of trigeminal primary afferents. We report a dual (pro-and anti-nociceptive) role of 5-HT in peripheral sensory traffic and present the neuropharmacology of these effects. This study improves our understanding of basic principles of nociceptive signaling and opens new perspectives for selective treatment of migraine pain at different levels of the nociceptive system.
Results
Long-lasting activation of peripheral nerve terminals by 5-HT
To study the effect of 5-HT on excitability of the peripheral trigeminal nerve terminals, we performed the suction electrode recordings from the n. spinosus in the hemiskull preparation. Spontaneous discharges in this meningeal nerve in control were compared with those observed in the presence of 5-HT. Application of 5-HT (20 mM for 10 min) induced a robust firing in the trigeminal nerve branches (Fig. 1A) . A characteristic feature of the firing evoked by 5-HT was its persistence (Fig. 1A and B) . Thus, despite a very fast removal of the free agonist under our experimental conditions, perfusions lasting as long as 20e30 min were required to restore firing frequencies seen in control. The lowest 5-HT concentration tested (0.2 mM) insignificantly increased the global firing in the trigeminal nerve terminals (to 219 ± 95%, p ¼ 0.38, n ¼ 4; Fig. 1C ). However, a strong enhancement of firing was seen in 2, 20 or 100 mM 5-HT (increase to 571 ± 228%, p ¼ 0.031, n ¼ 6; 683 ± 139%, p ¼ 0.0009, n ¼ 11; 331 ± 85%, p ¼ 0.001, n ¼ 13, respectively). Fig. 1C shows changes in the spiking frequency observed in different 5-HT concentrations, which are presented as a ratio of multiple unit activity (MUA) counts in 5-HT (during 5e10 min) and control (during last 5 min prior 5-HT application).
Thus, 5-HT applied to peripheral sites evoked large and persistent activity of the trigeminal nerve terminals.
Variable responses of spike clusters to 5-HT
Cluster spike analysis (Zakharov et al., 2015) was applied to study the 5-HT effect on individual fibers or small groups of fibers in the nervus spinosus. Plotting the spike amplitude versus duration revealed distinct spike clusters. Each cluster represents a single fiber or small group of nerve fibers of the same type in the trigeminal nerve (Zakharov et al., 2015) . Fig. 2A and B shows analysis of three clusters identified in the same nerve which, however, responded differently to the 5-HT application. Essential number of clusters (71%, 231 of total 327 clusters detected in 34 preparations) increased their firing (responders), while others either reduced firing (13%, 42 clusters, suppressed) or did not show alterations in their firing behavior (16%, 54 clusters, non-responders).
More than half of the clusters (53%) were already activated at the lowest 5-HT concentration tested (0.2 mM, Fig. 2C ), at which no significant effect on the overall nerve activity was observed. The fraction of responders grew with 5-HT concentration reaching its maximum at 2e20 mM (72e73%, Fig. 2C ). It should be noted that the number of responders was higher than the number of suppressed clusters ( Fig. 2C and D ) being in agreement with the overall pronociceptive effect of 5-HT in the whole nerve.
It should be noted that we did not observe 5-HT-induced changes in the amplitude and duration of individual spikes in each cluster (Fig. 2E, shown for the responders) . The only parameter which changed in the presence of 5-HT was the discharge frequency ( Fig. 2C and D) .
To get insight into the origin of the long-lasting effects of 5-HT on the whole nerve ( Fig. 1A and C) , we studied the time course of the response of individual clusters. In a population of responders, most clusters (60e70%) showed a prolonged increase in firing exceeding the period of the drug application (persistent clusters), whereas the remaining clusters responded transiently (transient clusters) (Fig. 3A) . The fraction of the persistent clusters increased with 5-HT concentrations (Fig. 3B) in consistency with the induction of the long-lasting overall activity observed in the whole nerve ( Fig. 1A and C) .
Thus, the clustering approach revealed that single fibers in the trigeminal nerve innervating cranial meninges represent a heterogeneous population in relation to their responses to 5-HT application.
Neurochemical profile of meningeal fibers
The cluster approach was further used to describe the neurochemical profile of meningeal fibers. Some clusters (Fig. 4Aa) responded to 5-HT, to the algogen ATP (100 mM) and to the TRPV1 agonist capsaicin (1 mM). However, there were clusters which responded only to 5-HT and ATP (Fig. 4Ab) or only to capsaicin (Fig. 4Ac) . Thus, afferents of the nervus spinosus showed a highly heterogeneous profile of chemical sensitivity (Fig. 4B , summary of 54 clusters). In a total population, 15% of clusters were co-activated by 5-HT, ATP and capsaicin, 7% by 5-HT and ATP, and 31% by 5-HT and capsaicin. In 11% of cases, the terminals were purely responsive to 5-HT.
We also tested the sensitivity of spikes elicited by 5-HT to the Na þ channel blocker TTX (1 mM). The firing was almost completely blocked by the drug (not shown). This indicated that 5-HT acts mainly on nerve fibers expressing TTX-sensitive Na þ channels at peripheral terminals, which can be afferents of both Ad-and C-type (Pinto et al., 2008) .
Spectral analysis of 5-HT-induced firing
Intensity of pain depends on the total number of spikes generated in the nociceptive fibers as well as on the frequency of spike discharges (Tong and MacDermott, 2014; Zhang et al., 2004) . Therefore, we compared the prevailing discharge frequencies of responders (notably, here each cluster corresponded to a single fiber) in control and after 5-HT application by analyzing the peaks of their interspike interval distributions ( Fig. 5A and B) . In control, the d-(1e4 Hz) and q-rhythms (4e8 Hz) were prevailing in 40% and 27% of trigeminal fibers, respectively ( Fig. 5A and B) . Autocorrelogram analysis was used to separate and analyze the clusters originating from single fibers (Fig. 5C ).
In the presence of 20 mM 5-HT, the prevailing frequency of responders still corresponded to the d-(43%) and q-rhythms (27%).
However, the number of fibers firing at these frequencies became much higher with respect to control (Fig. 5A) . In some fibers, 5-HT additionally induced firing at a frequency around 17 Hz (Fig. 5A) , which could facilitate temporal summation of excitatory inputs on the brainstem or spinal dorsal horn neurons (Zakharov et al., 2015) .
Receptor mediating the peripheral 5-HT effect
One of aims of this study was to identify the type of 5-HT receptor mediating direct excitation of the trigeminal nerve terminals. Since previous studies suggested the role of ionotropic 5-HT3 receptor (see Introduction), we first tested the effect of the specific 5-HT3 antagonist MDL-72222 (30 mM) on the 5-HT-induced discharge in the meningeal terminals. We found that an increase in the overall firing activity evoked in the meningeal nerve by 20 mM 5-HT (to 801 ± 174%, p ¼ 0.0002, n ¼ 13, Fig. 6A and C) was considerably reduced in the presence of MDL-72222 (to 280 ± 70%, n ¼ 9, p ¼ 0.0062 vs 5-HT alone, Fig. 6B and C) .
These results suggested the important role of 5-HT3 receptors in the action of 5-HT. Consistent with this view, the selective 5-HT3 agonist mCPBG at low concentrations (0.2 mM) significantly increased nociceptive firing (to 233 ± 40%, p ¼ 0.008, n ¼ 8, Fig. 6D ) 20 and 100 mM 5-HT and during the 10 min washout period. The numbers of preparations are: 4, 6, 11 and 13, respectively. *, p < 0.05; **, p < 0.01; ***, p < 0.001. In order to test directly the presence of 5-HT3 in trigeminal neurons we compared membrane currents activated by application of 20 mM 5-HT and the specific agonist mCPBG (20 mM) to isolated cultured cells. 5-HT induced currents in 23% (45/192) of neurons whereas mCPBG activated 21% (13/60) of neurons. Fig. 6E shows typical desensitizing currents induced by paired (interval 5 s) applications of these agonists. Notably, in contrast to 5-HT activated currents which recovered in few seconds, second application of mCPBG in 5 s induced no current (Fig. 6E) suggesting prolonged desensitization state for 5-HT3 receptors activated by mCPBG.
Immunohistochemical labelling of the meninges was carried out to localize the 5-HT3 receptors in the dural trigeminal nerves. Omission of secondary antibodies and pre-incubation of primary antibodies with a corresponding peptide served as negative controls. Nerve fibers immunopositive to 5-HT3A receptors were found in close proximity to the dura mater blood vessels (Fig. 6F) . Some 5-HT3-receptor-positive fibers contained neurofilaments (Fig. 6F) , a neurochemical marker of myelinated A-fibers Vang et al., 2012) , whereas others did not (not shown).
Taken together, these results suggested a major role of 5-HT3 receptors in activation of the trigeminal nerve terminals by 5-HT.
Meningeal mast cells as a potential 5-HT source
Since 5-HT is contained in granules of dural mast cells (Levy, 2009), we tested whether they may serve as a source of endogenous 5-HT release in the cranial meninges to activate local afferents. As expected, application of the compound 48/80 at 10 mg/ml concentration to meninges evoked degranulation of the mast cells in our hemiskull preparation (Fig. 7A ). This application also induced a persistent nociceptive firing in the trigeminal nerve endings (250 ± 43% of control, p ¼ 0.0001, n ¼ 27, Fig. 7B ). The 5-HT3 receptor antagonist (MDL-72222, 30 mM) prevented effect of the compound 48/80 on firing (p ¼ 0.72, n ¼ 6, Fig. 7C ), suggesting that endogenous 5-HT contributed to the excitation of nerve terminals caused by the mast cell degranulation. Histamine (100 mM), which could be also released from mast cells, produced only insignificant increase in the afferent firing (126 ± 17%, p ¼ 0.16, n ¼ 6, Suppl Fig. 1A and C) , whereas lowering pH to 5.4 which is often used for preparation of the inflammatory soup, largely facilitated spiking activity (1053 ± 474%, p ¼ 0.0039, n ¼ 9, Suppl Fig. 1B and C) like the powerful pro-nociceptive capsaicin (Suppl Fig. 1C ).
5-HT-evoked Ca 2þ transients in the trigeminal cells
As somata of trigeminal neurons could also contribute to the nociceptive signaling (Amir and Devor, 1996; Thalakoti et al., 2007) we tested the action 5-HT on trigeminal ganglion cells. The Ca 2þ imaging technique was also used to study functional expression of (E) Membrane currents in trigeminal neurons activated by paired (interval 5 s) application for 2 s of 20 mM 5-HT (left) and 20 mM mCPBG (right). Notice very poor recovery of currents after first application of mCPBG. (F) Immunohistochemical staining of 5eHT3A receptor expressed in a sensory nerve fiber, which localized near the blood vessel in cranial dura mater. The nerve fiber was costained with antibodies against the light chain of neurofilaments (NF) that revealed the neurochemical profile of the myelinated A-fiber (merged image, right).
5-HT receptors in the trigeminal ganglion neurons and satellite glial cells (SGCs). To better characterize responding cells, effect of 20 mM 5-HT was compared with that of 1 mM capsaicin. We used the cellpermeable Ca 2þ indicator fluo-3AM to measure changes in the level of intracellular Ca 2þ . Cell stimulation with 5-HT (for 20 s) and capsaicin (for 2 s) was followed by the application of a solution containing 50 mM KCl, to distinguish neurons from the SGCs . The 5-HT application evoked fast intracellular Ca 2þ transients in 33 of 154 neurons (21%, Fig. 8A and B) . The majority of 5-HT sensitive neurons also responded to capsaicin (70%, Fig. 8A and B) indicating the functional co-expression of 5-HT and TRPV1 receptors. It should be noted that higher number of neurons in our preparation responded to capsaicin only (Fig. 8B ). In addition, 5-HT excited a fraction of SGCs (29 of 138 cells, 21%, Fig. 8A and C). The 5-HT3 receptor agonist mCPBG (2 mM) activated 9 of 34 trigeminal neurons (26%, not shown). However, mCPBG had no effect on SGCs indicating the predominant neuronal expression of 5-HT3 receptors. In agreement with this, 5-HT-evoked Ca 2þ transients in neurons disappeared in Ca 2þ -free bath solution indicating that they were mediated by the extracellular Ca 2þ influx (Suppl Fig. 2A ). In contrast, responses of trigeminal satellite glial cells persisted in Ca 2þ -free bath solution suggesting that they were mostly mediated by Ca 2þ release from the intracellular stores (Suppl Fig. 2B ). Thus, a fraction of trigeminal ganglion cells expressed functional 5-HT3 receptors, which were responsible for the 5-HT-induced firing in the peripheral nerve terminals. Furthermore, the 5-HT receptors were mainly found in a subpopulation of peptidergic neurons expressing TRPV1 receptors (Julius and Basbaum, 2001) predicting that 5-HT may evoke CGRP release.
Action of 5-HT on CGRP release
We also studied whether 5-HT can evoke release of the key migraine mediator CGRP, which is stored in large dense core vesicles of peptidergic terminals in the meninges (Durham and Russo, 1999 ). 5-HT (100 mM) was applied to isolated hemiskulls and the level of CGRP was determined using a standard enzyme immunoassay kit. 5-HT significantly increased the release of CGRP from the trigeminal nerve terminals (34 ± 2.9 pg/ml versus 20 ± 1.7 pg/ml in control, n ¼ 5, p ¼ 0.002, Fig. 9A ). In the presence of 30 mM MDL- 
5-HT inhibits the central terminals of trigeminal afferents
As the central (presynaptic) terminals of the trigeminal nerve relay peripheral nociceptive input to the second order neurons in the trigeminocervical complex, we also tested the 5-HT action at this site. The experiments were designed to reveal presynaptic effects induced by 5-HT. For this, whole-cell recordings from upper cervical lamina I neurons were carried out to analyze the 5-HTinduced changes in the magnitude of the monosynaptic EPSCs evoked by stimulating trigeminal Ad-and C-afferents (Fig. 10, bottom inset). We found that 20 mM 5-HT reversibly reduced evoked EPSCs to 39.3 ± 25.8% (n ¼ 8, p < 0.05; Fig. 10A , C). It should be noted that 5-HT had effects on the monosynaptic EPSCs mediated via both Ad-and C-fibers (Fig. 10A) . Application of MDL-72222 (20 mM) did not affect the EPSC amplitudes by itself (113.4 ± 12.2%, n ¼ 5, p ¼ 0.07, Fig. 10B and C) but prevented the effect of the following 5-HT application (105.0± 14.3% of control, n ¼ 4, p ¼ 0.53; Fig. 10B ). These data suggested that 5-HT provides an inhibitory control of the activity of the central terminals of Ad-and C-fiber trigeminal afferents via presynaptic 5-HT3 receptors.
Discussion
The main finding of the present study is that 5-HT acting via the 5-HT3 receptor induces a dual effect: powerful long-lasting pronociceptive firing along with CGRP release in the peripheral meningeal terminals of the trigeminal nerve, and anti-nociceptive presynaptic inhibition of its central terminals. Our cluster approach revealed a high heterogeneity of the 5-HT effects induced at the level of single trigeminal fibers innervating cranial meninges. Taken together, this study provides a rationale for the regionspecific control of nociceptive firing as a basis for specific therapy of migraine pain.
5-HT receptors in the trigeminal nociceptive system
5-HT is an endogenous neurotransmitter and neuromodulator operating via several metabotropic receptors and one ionotropic receptor of the 5-HT3 type. There are five subtypes of the 5-HT3 receptor (5-HT3A-E); the 5-HT3A subtype being most widely expressed (Niesler, 2011) .
The important role of the 5-HT3 receptor contributing to activation of peripheral branches of meningeal afferents in the current study was confirmed by the inhibitory effect of the selective 5-HT3 blocker MDL-72222 and pro-nociceptive activity of the 5-HT3 agonist mCPBG. Further support was obtained by specific labelling of the trigeminal nerve fibers with the 5-HT3A receptor antibody and direct activation of 5-HT3 receptor mediated currents in a fraction of trigeminal neurons. It has been shown previously that 5-HT3 receptors are expressed in both myelinated Ad-and some unmyelinated C-fibers (Martin et al., 1998) , and their activation by intraplantar injection of 5-HT evokes acute pain (Sufka et al., 1992) . Accordingly, functional elimination of the 5-HT3 receptor reduces tissue injury-induced nociception in mice (Zeitz et al., 2002) . 5-HT3 receptors are also involved in vasodilation induced by 5-HT in dura mater (Lambert et al., 2004 ). Here we show that 5-HT3 receptors in meningeal fibers mediate also release of the neuropeptide CGRP, a principal trigger of migraine, which may cause neurogenic inflammation and migraine headache.
It should be noted however, that although multiple evidence indicates an important role of 5-HT3 receptor in trigeminal nociception, some contribution of other 5-HT receptors cannot be excluded. Indirectly this view is supported by complete prevention of the 5-HT-induced firing with combination of MDL-72222 and GR127935. An involvement of 5-HT1B/D receptor is unlikely since sumatiptan alone or with mCPBG failed to activate firing. Thus, the role of receptors other than 5-HT1B/D, for instance, 5-HT2 receptor (Segelcke and Messlinger, 2016) should be studied in future experiments.
Novel properties of cranial nociceptors revealed by the clustering approach
Cluster analysis of the trigeminal nerve firing (Zakharov et al., 2015) was used to characterize the responses of individual afferents to 5-HT application. The high percentage of responders (~70%) was close to that reported for the trigeminal nerve activation by capsaicin (65%, Zakharov et al., 2015) . The cluster analysis identified highly sensitive trigeminal fibers activated by nanomolar 5-HT concentrations. According to the time-course of the 5-HT-induced discharges, the population of responders was very heterogeneous including persistently activated fibers likely underlying the longlasting 5-HT-induced pain sensitization. Indeed, 5-HT, as a key component of the inflammatory soup (Strassman et al., 1996; Burstein et al., 2005; Oshinsky and Gomonchareonsiri, 2007; Luk acs et al., 2015) , can induce sensitization of the trigeminal nociceptive system underlying migraine pain. Consistent with the major role of 5-HT, histamine was much less effective.
We have also found that, in addition to an augmentation of the prevailing d-and q-rhythm firing, 5-HT evoked, in individual fibers, a high-frequency discharge at 17 Hz. Such discharge frequencies may be sufficient to induce temporal summation of nociceptive inputs in the spinal dorsal horn neurons (Zakharov et al., 2015) and ensure their relay to higher pain centers.
5-HT-induced Ca 2þ transients and CGRP release
5-HT excited somata of trigeminal ganglion neurons, which are also considered as potential contributor to migraine pain (Messlinger, 2009 -dependent enzyme CaMKII contributing to migraine pain (Simonetti et al., 2008) . Interestingly, the majority of the 5-HT-sensitive trigeminal neurons, similarly to peripheral nerve terminals co-expressed TRPV1 and 5-HT receptors, providing a rationale to our previously found enhancement of capsaicin-activated currents by 5-HT .
The increase in the CGRP release in the dura mater mediated via the 5-HT3 receptor described here can, along with other proinflammatory agents, such as substance P, prostaglandins (Ebersberger et al., 1999) sensitize trigeminal system. CGRP induces neurogenic inflammation of the dura mater (Olesen et al., 2009) , probably via vasodilation and directly causing activation of neurons (Markowitz et al., 1987) , it can trigger ATP release (Yegutkin et al., 2016) and up-regulate the expression of pain-transducing P2X3 receptors . Thus, CGRP released in meninges could further augment afferent sensitization. Such sensitization can include activation of PKC, PKA and CaMKII, which, in turn, can enhance pain transduction by P2X3 receptors via protein trafficking and CREB-dependent transcription (Simonetti et al., 2008; Giniatullin and Nistri, 2013) .
Thus, 5-HT demonstrated several pro-nociceptive effects in the peripheral part of the trigeminal system. It enhanced nociceptive firing in meningeal terminals, elevated intracellular Ca 2þ in trigeminal ganglion neurons and satellite cells, and triggered the release of the algogen CGRP.
5-HT3 receptors at central terminals of Ad-and C-afferents
5-HT3 receptors are also expressed in the central terminals of afferents (Martin et al., 1998) where they modulate nociceptive inputs to the spinal cord (Khasabov et al., 1999) . Lamina I is the major output unit of the spinal nociceptive network. Neurons in the upper cervical cord, a part of the trigeminocervical complex, relay afferent inputs from the cranial meninges and cervical somatic structures, and serve as the neural substrate of primary headache syndrome (Bartsch and Goadsby, 2003) . We found that the 5-HT3 receptor essentially contributes to the 5-HT induced presynaptic inhibition of Ad-and C-afferents supplying lamina I neurons and therefore can effectively control the nociceptive drive to the spinal cord. This 5-HT3-receptor-mediated inhibition may function via depolarization of primary afferents and inactivation of the voltagegated Na þ channels leading to reduced involvement of Ca 2þ channels responsible for transmitter release in the central terminals (Rudomin and Schmidt, 1999) . The presynaptic inhibition may be caused by the tonic activity of serotonergic neurons located in the rostral posterior medulla (RPM, Kim et al., 2014) . Such central control may involve direct synapses of serotonergic descending axons onto the central terminals of primary afferents (Zhang et al., 2015) . The inhibitory central effect of 5-HT on synaptic transmission was consistent with the depressant action of 5-HT on CGRP release in the brainstem which could also involve 5-HT1B/D receptors (Goadsby and Edvinsson, 1993; Goadsby and Hoskin, 1998; Donaldson et al., 2002 Amrutkar et al., 2012 . However, given the complicated local neuronal network in the spinal dorsal horn and brainstem, the central effects of 5-HT are likely involve several subtypes of 5-HT receptors. Moreover, in certain pain conditions there are could be alterations in descending serotonergic modulation of the nociceptive pathways (Kim et al., 2014) . Taken together, the current evidence suggests that central serotonergic control is tunable and could be differently presented in normal versus pain conditions.
Pathophysiological implications in migraine
Our results suggest that 5-HT released from dural mast cells (Levy, 2009; Tore and Tuncel, 2011) and/or aggregated platelets (Taffi et al., 2005) induces nociceptive firing in nerve terminals. The effect can become long-lasting due to contributing vasodilation (Lambert et al., 2004) , extravasation (Williamson et al., 1997) and neuro-inflammation triggered by multiple pro-inflammatory compounds, including ATP (Yegutkin et al., 2016) and CGRP (Markowitz et al., 1987; Fabbretti et al., 2006) . However, activation of the peripheral meningeal nerve endings by 5-HT could be counterbalanced, by its inhibitory action on the central terminals synapsing on lamina I neurons in the brainstem and upper cervical spinal cord. The weakening of this presynaptic inhibition in migraine can 'open gates' for peripheral pain signals. The balance between excitatory peripheral and central inhibitory effects could determine the final contribution of 5-HT to the migraine pain state.
Conclusion
In conclusion, we report a robust nociceptive activity and CGRP release induced by 5-HT in peripheral nerve terminals mainly via 5-HT3 receptors. Cluster analysis revealed highly heterogeneous profiles of nociceptive activity including long-lasting firing. Ca 2þ imaging indicated essential co-expression of 5-HT and TRPV1 receptors in trigeminal neurons. Interestingly, peripheral nociceptive activation was combined with the inhibitory action of 5-HT at central nerve terminals of meningeal nociceptors through the same 5-HT3 receptor. Thus, our data suggest that 5-HT plays a dual role in migraine: multicomponent pro-nociceptive peripheral action and inhibitory effect in the central terminals of meningeal nociceptors.
